Crowdsourced science refines AI prediction of clinical trial outcomesThink of the R&D dollars that could be saved if artificial intelligence (AI) modelling could tell you at Share XCrowdsourced science refines AI prediction of clinical trial outcomeshttps://pharmaphorum.com/news/crowdsourced-science-refines-ai-prediction-of-clinical-trial-outcomes/
Computer model simulates COVID infection, and treatmentResearchers in Canada have built a computer model that replicates how the human immune system interacts with the Share XComputer model simulates COVID infection, and treatmenthttps://pharmaphorum.com/news/computer-model-simulates-covid-infection-and-treatment/
Dopavision raises €12m for DTx to tackle myopia epidemicDigital therapeutics (DTx) startup Dopavision has raised funding to develop its lead product, an app designed to slow Share XDopavision raises €12m for DTx to tackle myopia epidemichttps://pharmaphorum.com/news/dopavision-raises-e12m-for-dtx-to-tackle-myopia-epidemic/
Elekta to work with academics on AI-directed radiotherapyRadiotherapy specialist Elekta has joined forces with two academic groups in the Netherlands to explore the use of Share XElekta to work with academics on AI-directed radiotherapyhttps://pharmaphorum.com/news/elekta-to-work-with-academics-on-ai-directed-radiotherapy/
AI-driven ‘clock’ predicts aging-related illness and mortalityScientists in the US have developed an artificial intelligence-powered ‘clock’ that can estimate a person’s chance of developing Share XAI-driven ‘clock’ predicts aging-related illness and mortalityhttps://pharmaphorum.com/news/ai-driven-clock-predicts-aging-related-illness-and-mortality/
How’s my driving? GPS tracking spots Alzheimer’s with 86% accuracyDiagnosing Alzheimer’s disease is still a challenge, particularly in its earliest stages, but a new study suggests that Share XHow’s my driving? GPS tracking spots Alzheimer’s with 86% accuracyhttps://pharmaphorum.com/news/hows-my-driving-gps-tracking-spots-alzheimers-with-86-accuracy/
Digitisation key to improving mental health services in England; reportFaced with a looming mental health crisis, the UK government has been urged to invest in the digitisation Share XDigitisation key to improving mental health services in England; reporthttps://pharmaphorum.com/news/digitisation-key-to-improving-mental-health-services-in-england-report/
Merck makes another bioelectronics play, partnering with InnerviaMerck KGaA has forged a second partnership in the bioelectronics category in two weeks, teaming up with Innervia Share XMerck makes another bioelectronics play, partnering with Innerviahttps://pharmaphorum.com/news/merck-makes-another-bioelectronics-play-partnering-innervia/
Sonde Health partners with Qualcomm on vocal biomarker techSonde Health has joined forces with chipmaker Qualcomm to develop a technology platform that could diagnose human health Share XSonde Health partners with Qualcomm on vocal biomarker techhttps://pharmaphorum.com/news/sonde-health-partners-with-qualcomm-on-vocal-biomarker-tech/
Gates Foundation backs COVID R&D at AI firm ExscientiaArtificial intelligence-based drug discovery company Exscientia is stepping up its search for new COVID-19 medicines, thanks to an Share XGates Foundation backs COVID R&D at AI firm Exscientiahttps://pharmaphorum.com/news/gates-foundation-backs-covid-rd-at-ai-firm-exscientia/
Digital health investment has skyrocketed; now expect consolidationA record $14.7 billion in investments was injected into US digital health companies in the first half of Share XDigital health investment has skyrocketed; now expect consolidationhttps://pharmaphorum.com/news/digital-health-investment-has-skyrocketed-now-expect-consolidation/
Unsure whether to get a COVID-19 jab? Just ask Vira!With COVID-19 vaccine hesitance an increasing concern in the US, researchers at Johns Hopkins have developed a chatbot Share XUnsure whether to get a COVID-19 jab? Just ask Vira!https://pharmaphorum.com/news/unsure-whether-to-get-a-covid-19-jab-just-ask-vira/
Pharma execs join DigitalEurope’s new health councilSenior figures from GlaxoSmithKline, Roche, Bayer, and Johnson & Johnson have been named to an 18-strong executive council Share XPharma execs join DigitalEurope’s new health councilhttps://pharmaphorum.com/news/pharma-execs-join-digitaleurope-new-health-council/
Merck partners neuroloop on bioelectronic device for inflammationMerck KGaA has joined forces with a unit of medtech firm B Braun – neuroloop – on a Share XMerck partners neuroloop on bioelectronic device for inflammationhttps://pharmaphorum.com/news/merck-partners-neuroloop-on-bioelectronic-device-for-inflammation/
Manchester joint venture will trial Morningside’s digital health portfolioThe University of Manchester has formed a joint venture with Morningside to carry out clinical trials of various Share XManchester joint venture will trial Morningside’s digital health portfoliohttps://pharmaphorum.com/news/manchester-joint-venture-will-trial-morningsides-digital-health-portfolio/
NIH starts trial of Pear, Chess apps for opioid use disorderPatient recruitment has begun in a National Institutes of Health (NIH) trial of two digital therapeutics (DTx) for Share XNIH starts trial of Pear, Chess apps for opioid use disorderhttps://pharmaphorum.com/news/nih-starts-trial-of-pear-chess-apps-for-opioid-use-disorder/
WHO cautions against overestimating AI’s impact on healthArtificial intelligence (AI) has the potential to improve the delivery of healthcare, but only if ethics and human Share XWHO cautions against overestimating AI’s impact on healthhttps://pharmaphorum.com/news/who-cautions-against-overestimating-ais-impact-on-health/
Andy Molnar named head of Digital Therapeutics AllianceFormer Cognoa executive Andy Molnar has been appointed chief executive of the Digital Therapeutics Alliance, a global trade Share XAndy Molnar named head of Digital Therapeutics Alliancehttps://pharmaphorum.com/news/andy-molnar-named-head-of-digital-therapeutics-alliance/
